Jindal Vineet R. 4
4 · Reneo Pharmaceuticals, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Jindal Vineet R.
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-10+30,000→ 36,600 total - Award
Stock option (right to buy)
2021-12-10+100,000→ 100,000 totalExercise: $6.69Exp: 2031-12-09→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit award.
- [F2]Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2021.
- [F3]The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.